Free Trial

Voyageur Pharmaceuticals (CVE:VM) Trading 21.8% Higher - Here's Why

Voyageur Pharmaceuticals logo with Medical background

Voyageur Pharmaceuticals Ltd. (CVE:VM - Get Free Report)'s share price rose 21.8% during mid-day trading on Friday . The company traded as high as C$0.36 and last traded at C$0.34. Approximately 790,132 shares were traded during mid-day trading, an increase of 306% from the average daily volume of 194,652 shares. The stock had previously closed at C$0.28.

Voyageur Pharmaceuticals Trading Up 23.6%

The company has a debt-to-equity ratio of 4.23, a current ratio of 0.10 and a quick ratio of 0.84. The firm has a market cap of C$51.52 million, a PE ratio of -31.80 and a beta of 0.32. The stock's fifty day simple moving average is C$0.19 and its 200-day simple moving average is C$0.16.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Voyageur Pharmaceuticals Right Now?

Before you consider Voyageur Pharmaceuticals, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Voyageur Pharmaceuticals wasn't on the list.

While Voyageur Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines